Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsIv (Infusion)Standard

VFEND

VORICONAZOLE

Standard Dose
200MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview VFEND is listed in Drugs@FDA under application 021466 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient VORICONAZOLE Form and strength Injectable; Iv (Infusion) - 200MG/VIAL Sponsor PFIZER Submission history Latest submission status date: 2003-11-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview VFEND is listed in Drugs@FDA under application 021466 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient VORICONAZOLE Form and strength Injectable; Iv (Infusion) - 200MG/VIAL Sponsor PFIZER Submission history Latest submission status date: 2003-11-14 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.